Results
Filtros
Meeting in São Paulo discusses the future of medicinal cannabis in Brazil
The Brazilian Association of Cannabinoid Industry (BRcann) forum brought together sector representatives and Anvisa to discuss regulatory updates, research, information, and market
Anvisa approves new framework for herbal medicines in Brazil
New regulation simplifies registration and expands the use of biodiversity in herbal medicines, as soon as cannabis products are classified as medicines, they must comply with these standards.
Growth of the medicinal cannabis market in Brazil: a revolution in numbers and health
The expansion of the industry and the transformation in patients' lives
One year after Anvisa's approval, MAPA still does not regulate veterinary cannabis
Without defined rules, veterinarians face legal uncertainty and animals still have limited access to medicinal cannabis treatment
Between Advances and Prejudices: Restrictions on Cannabis Product Advertising
12/21/2021Unrestricted prohibitions on Cannabis products currently in force are not in line with Anvisa's regulatory microsystem.
Globo Rural covers medicinal cannabis and industrial hemp in special report
Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.
Anvisa discusses review of regulation of medicinal cannabis products
Public consultation proposal for the review of RDC No. 327/2019 will be evaluated by the Collegiate Board on December 19, 2024
Anvisa updates control of substances and redefines rules for medicinal cannabis
New RDC No. 1,011 expands regulatory details on Cannabis derivatives, medicinal products, and pharmaceutical inputs
Maceió to host open class on medical cannabis this Friday (07)
Initiative complies with State Law 8,754/22 and aims to prepare professionals to prescribe cannabis safely and legally
SUS and Health Insurance Plans
01/01/2024Learn How to Access Cannabis Products Through the Unified Health System and Understand the Obligations of Health Insurance Providers
Specific regulations and emerging scientific evidence support dentists in prescribing cannabis
Explore the scientific foundations and clinical practices that support the use of cannabis in dental treatment
Hemp Makeup? The Green Beauty Challenging Regulation
Hemp is making its way into makeup with promises of natural beauty, but still faces challenges in regulation and skin science
We Are Not Drug Dealers!
In his debut column for Sechat, veterinarian Erik Amazonas evaluates the latest statement issued by the Federal Council of Veterinary Medicine (CFMV) regarding the prescription of cannabis-derived products.
Regulation of Cannabis Products for Medicinal Purposes Enters Anvisa's Regulatory Agenda 2024-2025
Review of the Brazilian Pharmacopoeia collegiates is also included in the Agenda
Cannabis in Nature in Brazil: the dilemma between prohibition and freedom of access
07/21/2023Faced with Anvisa's prohibition on the importation of cannabis flowers, market players diverge in opinions
Professor Advocates for Inclusion of Physical Therapists in Cannabis-Based Treatment
COFFITO Ruling No. 735/2024 authorizes physical therapists with specific training to prescribe medications and supplies; however, Anvisa recognizes only doctors and dentists as prescribers of cannabis for medicinal purposes
Anvisa publishes new RDC 1.015 and redefines the regulatory framework for medicinal cannabis in Brazil
Resolution No. 1,015/2026 tightens technical requirements, expands sanitary controls, and consolidates authorization as a transitional step before the registration of medicines
How RDC 660 ensures diversified products and support for doctors in different diseases
Paula Scanapieco, a specialist in medical cannabis logistics, speaks on Deusa Cast about the importance of RDC 660, product quality, and the role of companies in providing reliable information to doctors and patients in Brazil
Anvisa rectifies RDC No. 1,015 and adjusts labeling rules for cannabis products
Correction published in the Official Gazette clarifies requirements on packaging and maintains authorization for magistral manipulation of CBD
Deusa Cast discusses the update of RDC 660 and access to medicinal cannabis in Brazil
Episode addresses the update of RDC 660, international certification, and challenges to expand access to treatments with different cannabinoids in Brazil.